Onconova Therapeutics (NASDAQ:ONTX) Downgraded by Zacks Investment Research to Hold

Onconova Therapeutics} stock has undergone multiple analysts rating changes in the recent past.  Onconova Therapeutics Downgraded by Zacks Investment Research on 10/14/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Buy.

View More Onconova Therapeutics (NASDAQ:ONTX) Downgraded by Zacks Investment Research to Hold